ScoreWhy is Valiant Laboratories Ltd ?
1
Weak Long Term Fundamental Strength with a -49.92% CAGR growth in Operating Profits over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.65
- The company has been able to generate a Return on Equity (avg) of 0.80% signifying low profitability per unit of shareholders funds
2
With ROE of 1.6, it has a Expensive valuation with a 1.2 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -39.36%, its profits have risen by 150.8% ; the PEG ratio of the company is 0.5
3
Below par performance in long term as well as near term
- Along with generating -39.36% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Valiant Laborato for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Valiant Laborato
-38.35%
-0.87
44.24%
Sensex
4.83%
0.41
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-17.24%
EBIT Growth (5y)
-49.92%
EBIT to Interest (avg)
0.65
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.03
Sales to Capital Employed (avg)
0.68
Tax Ratio
4.16%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
-0.72%
ROE (avg)
0.80%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
75
Industry P/E
34
Price to Book Value
1.21
EV to EBIT
77.65
EV to EBITDA
54.05
EV to Capital Employed
1.21
EV to Sales
2.01
PEG Ratio
0.54
Dividend Yield
NA
ROCE (Latest)
1.56%
ROE (Latest)
1.60%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
Bearish
Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend20What is working for the Company
NET SALES(Latest six months)
At Rs 93.02 cr has Grown at 130.48%
PAT(Latest six months)
At Rs 2.02 cr has Grown at 138.48%
-6What is not working for the Company
OPERATING CF(Y)
Lowest at Rs 1.31 Cr
PBT LESS OI(Q)
At Rs -0.59 cr has Fallen at -7.8% (vs previous 4Q average
Loading Valuation Snapshot...
Here's what is working for Valiant Laborato
Net Sales - Latest six months
At Rs 93.02 cr has Grown at 130.48%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (Rs Cr)
Profit After Tax (PAT) - Latest six months
At Rs 2.02 cr has Grown at 138.48%
Year on Year (YoY)MOJO Watch
PAT trend is very positive
PAT (Rs Cr)
Profit After Tax (PAT) - Latest six months
Higher at Rs 2.02 cr
than preceding 12 month period ended Sep 2025 of Rs -2.20 crMOJO Watch
In the half year the company has already crossed PAT of the previous twelve months
PAT (Rs Cr)
Here's what is not working for Valiant Laborato
Operating Cash Flow - Annually
Lowest at Rs 1.31 Cr and Fallen
each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs -0.59 cr has Fallen at -7.8% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs -0.55 CrMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
